Business Wire

Netmore and Cibicom Enter Strategic Partnership for Denmark and Introduce Unified Roaming Across the Nordics

15.9.2026 09:00:00 EEST | Business Wire | Press release

Share

Netmore Group, the leading network operator for Massive IoT, today announced that Cibicom has selected Netmore’s Operator Platform-as-a-Service (PaaS) to operate, optimize, and scale its nationwide LoRaWAN® network for Internet of Things (IoT) deployments. Cibicom is the largest LoRaWAN network operator in Denmark and provides critical communication infrastructure for nationwide broadcast and LTE450 services as well as tier 3 data center solutions and B2B fiber connectivity. The partnership means that Cibicom will replace its existing LoRaWAN Network Server with Netmore’s ThingPark Platform and that the Parties will work strategically together to ensure Danish customers can benefit from comprehensive and reliable LoRaWAN connectivity across Denmark.

By leveraging Netmore's carrier-grade platform, Cibicom gains enhanced network scalability, seamless roaming, and high-availability features, improving its delivery of reliable, cost-effective connectivity to customers in utilities, energy management, manufacturing, healthcare, and other critical infrastructure and essential business segments.

Mette Slesvig, CEO Cibicom A/S, CEO of Cibicom, said: "Partnering with Netmore allows Cibicom to enhance our nationwide LoRaWAN infrastructure, ensuring we are in a strong position to adapt to evolving requirements and able to support new and emerging applications. With IoT and managed services becoming increasingly important, this partnership enables us to operate a highly efficient IoT network for our data-driven customers and strengthens Denmark's position in Massive IoT. At Cibicom, we are committed to delivering the best IoT solutions on Denmark's leading network, and this partnership guarantees just that."

Combined with Netmore's partnership with Digita in Finland and other public network deployments, this partnership establishes seamless LoRaWAN coverage across the entire Nordic region, including robust roaming capabilities for devices along the Nordic transport corridor. Together, these partnerships enable reliable cross-border applications in transportation, logistics, and environmental monitoring, driving greater operational efficiency and sustainability throughout the Nordics.

Ove Anebygd, CEO of Netmore, said: "This strategic partnership with Cibicom executes on our vision of enabling operators to deliver carrier-grade nationwide IoT connectivity while eliminating network fragmentation and contributing to unified, high-performance connectivity regionally and worldwide. With Netmore’s ThingPark Platform, Cibicom can focus on innovation and customer value in Denmark, while contributing to broader ecosystem synergies."

Janne Rannikko, VP, IoT at Digita, said: "Digita’s nationwide LoRaWAN network in Finland provides a strong foundation for Nordic interoperability as IoT deployments scale across borders. Delivering reliable cross-market connectivity requires carrier-grade infrastructure and operational discipline. This partnership extends that to customers in utilities, logistics, and other critical sectors operating across the Nordic region.”

For more information, contact Netmore at: https://netmoregroup.com/contact-us/

About Netmore Group

Netmore Group is the leading global network operator for Massive IoT, powering the world’s most advanced and sustainability-focused solutions for utilities, buildings, cities, and other markets that benefit from sensor-connected environments. With a decade of innovation and leadership in IoT platform development and network operations, Netmore continues to set the standard for IoT excellence. Netmore operates in 18 countries and is backed by Nordic infrastructure investor Polar Structure.

About Cibicom

Cibicom A/S is Denmark's leading critical digital infrastructure provider, operating the national radio/TV broadcast network, a nationwide LoRaWAN IoT network, and data centers. With a focus on reliable, open connectivity, Cibicom collects data from sensors across Denmark to support smart solutions in various sectors. While headquartered in Ballerup, our localized service teams ensure nationwide coverage, delivering robust and innovative services across the IoT, broadcast, and telecom industries. For more information, visit www.cibicom.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260914844528/en/

Contacts

Media Contact:
James Gerber
Crackle Communications
+1 508-233-3391
netmore@cracklepr.com

Netmore Contact:
Ken Lynch
VP, Global Marketing
+1 617-877-5393
ken.lynch@netmoregroup.com

Cibicom Contact:
Louis Lütken
Client Executive IoT
+45 7011 8011
lolu@cibicom.dk

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo ® ) in Patients With Mycosis Fungoides and Sézary Syndrome12.10.2026 09:00:00 EEST | Press release

Kyowa Kirin International plc, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced final results from the German MINT study evaluating mogamulizumab in patients with mycosis fungoides (MF) and Sézary Syndrome (SS). Presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG) Annual Meeting 2026 in Berlin, Germany, the findings represent one of the largest real-world evaluations of mogamulizumab in Germany and add to the growing body of evidence supporting its use in routine clinical practice.1-3 Conducted as a company-sponsored, multicentric, non-interventional, combined retro-prospective real-world study across 18 centres throughout Germany, MINT brought together cutaneous T‑cell lymphoma (CTCL) specialists to evaluate treatment outcomes with mogamulizumab in a real-world setting, with time-to-next-treatment (TTNT) as the study’s primary endpoint.1 The study captured a broad and heterog

Megaport Expands Global Automated Infrastructure Platform Into Portugal12.10.2026 09:00:00 EEST | Press release

Megaport Limited (ASX: MP1) (“Megaport”), a leading global automated infrastructure platform, today announced the launch of its services in Portugal, expanding its European footprint and enabling enterprises and service providers in the region to connect instantly to the world’s leading cloud, network, and data center providers. With new on-ramps in Lisbon, customers in Portugal can now access Megaport’s automated infrastructure platform as well as more than 1,200 enabled data centers worldwide. This launch gives enterprises, MSPs, and carriers private, high-performance compute, network, and storage, as well as on-demand regional interconnection with scalable bandwidth. With Portugal’s data center market projected to reach US$3.09 billion by 2030 as well as Lisbon’s proximity to major submarine cable landings, the strengthening global connectivity hub is a natural next step for Megaport. “Portugal’s digital economy is rapidly growing, and infrastructure is at the heart of that transfor

Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 202610.10.2026 19:09:00 EEST | Press release

Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010101303/en/ Filippo Fagnani receiving the prize with Olivier Traxer and Professor Bhaskar Somani. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precise, flexible and useful technologies, with the ultimate goal of supporting patient safety and better surgical outcomes. “I have always believed that technology should make the surgeon’s work more precise, more flexible and, most importantly, safer for the patient. My goal has never been to develop technology for its own sake,

Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 13:30:00 EEST | Press release

As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged

Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 20:15:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye